Table 1.
Whole study group | Survival in 5-yr follow-up | |
Gender | ||
Male | 56 (47.5) | 35 (62.5) |
Female | 62 (52.5) | 36 (58.1) |
Age, median (range) | 69 (36-89) | |
Other morbidities | ||
No | 27 (22.9) | 16 (59.3) |
Yes | 91 (77.1) | 55 (60.4) |
Other neoplasm | ||
No | 109 (92.4) | 62 (56.9) |
Sex organs or breast cancer | 2 (1.7) | 2 (100.0) |
Other cancer | 3 (2.5) | 3 (100.0) |
Colon adenoma | 4 (3.4) | 4 (100.0) |
Cancer in family | ||
No/not known | 104 (88.1) | 59 (56.7) |
CRC | 8 (6.8) | 7 (87.5) |
HNPCC family | 2 (1.7) | 2 (100.0) |
Other HNPCC-associated cancer | 3 (2.5) | 2 (66.7) |
Other cancer | 1 (0.8) | 1 (100.0) |
Type of operation | ||
Radical1 | 94 (80.3) | 69 (73.4) |
Palliative2 | 23 (19.7) | 2 (8.7) |
Location of tumour | ||
Proximal colon | 46 (39.0) | 27 (58.7) |
Distal colon | 39 (33.1) | 25 (64.1) |
Rectum | 32 (27.1) | 18 (56.3) |
Multiple tumours | 1 (0.8) | 1 (100.0) |
Radically operated distant metastases in a second operation in one case;
Metastases treated non-operatively in two cases (both alive at 5-year follow-up).